Vivally is an at-home, non-invasive therapy for urge urinary incontinence and urinary urgency without the need for surgery, implants, or drugs. (Image: Avation Medical)

Surgery- and drug-free at-home wearable neuromodulation represents a huge advancement for a variety of clinical conditions, including overactive bladder syndrome, which affects more than 46 million people in the U.S.

On this episode of Medical Design Briefs’ Podcast, Jill Schiaparelli, CEO of Avation Medical, discusses the first FDA-cleared, non-invasive, closed-loop wearable neuromodulation technology for at-home bladder treatment. From understanding the technology behind it to its real-world impact on patients and clinicians, this podcast uncovers the potential of wearable neuromodulation in revolutionizing the treatment of OAB.

Subscribe  to the Medical Design Briefs podcast on Apple Podcasts  or Spotify  .

 

Topics:
Biosensors Diagnostics Digital Health Health Monitors and Activity Trackers Medical Patient Monitoring Sensors Smart Patches and Bandages Smartwatches, Wristbands, and Eyeglasses Wearables Wearables

More From SAE Media Group

Podcasts
Wearable Injectors: The Future of Drug Delivery
Related article image
Podcasts
Navigating Clinical Trials with Wearables
Related article image
Podcasts
Continuous Monitoring: Biosensors for Health Insights
Related article image
Podcasts
Data Precision in Wearables: The Challenge of Accuracy
Related article image